The Alteration of Dialysate Cancer Antigen 125 Concentration Under a Biocompatible Bicarbonate Peritoneal Dialysis Solution and the Preservation of the Mesothelial Cell Viability-Reference-Cited by-同舟云学术

The Alteration of Dialysate Cancer Antigen 125 Concentration Under a Biocompatible Bicarbonate Peritoneal Dialysis Solution and the Preservation of the Mesothelial Cell Viability

Published:2008-01 Issue:2 Volume:30 Page:161-167
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Theodoridis M.,Passadakis P.,Kriki P.,Gioka T.,Panagoutsos S.,Mourvati E.,Thodis E.,Kantartzi K.,Vargemezis V.

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/08860220701808384

Reference31 articles.

1. Morphologic Changes in the Peritoneal Membrane of Patients with Renal Disease

2. The effect of dialysate on peritoneal phagocyte oxidative metabolism

3. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo

4. Changes in Biocompatibility of Dialysis Fluid during Its Dwell in the Peritoneal Cavity

5. Effects of Bicarbonate/Lactate Solution on Peritoneal Advanced Glycosylation End-Product Accumulation

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preserving the peritoneal membrane in long-term peritoneal dialysis patients;Journal of Clinical Pharmacy and Therapeutics;2015-08-17

2. Methylglyoxal and Advanced Glycation End-Products Promote Cytokines Expression in Peritoneal Mesothelial Cells Via MAPK Signaling;The American Journal of the Medical Sciences;2015-02

3. Intervenciones farmacológicas en el marco de la diálisis peritoneal: protegiendo el peritoneo;Diálisis y Trasplante;2013-07

4. Dialysate cancer antigen 125 in long-term peritoneal dialysis patients;Clinical and Experimental Nephrology;2013-06-12

5. PD solutions: New and old;Dialysis & Transplantation;2011-08